The DOI matches its Crossref record; 76 of the 78 references it cites were found in a registry or an index.
Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases
Open accessAbstract
The development of customizable sequence-specific nucleases such as TALENs, ZFNs and the powerful CRISPR/Cas9 system has revolutionized the field of genome editing. The CRISPR/Cas9 system is particularly versatile and has been applied in numerous species representing all branches of life. Regardless of the target organism, all researchers using sequence-specific nucleases face similar challenges: confirmation of the desired on-target mutation and the detection of off-target events. Here, we evaluate the most widely-used methods for the detection of on-target and off-target mutations in terms of workflow, sensitivity, strengths and weaknesses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When the indels are deposited at the coding sequences of a given gene, NHEJ can cause frameshift mutations, resulting in non-sense-mediated mRNA decay and gene silencing (Wang et al., 2016a; Zischewski et al., 2017; Lindeboom et al., 2019).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Zischewski et al., 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | LNP: Can be quickly degraded in vivo | Eliminate off-target effects |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Delivery methods improvement | Application in vivo [95–105] | AAV: Last for years in terminally differentiated cell types | May cause accumulation of off-target mutations |”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
Flagged first, then by citations
2 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 321
Paschon, V., Correia, F. F., Morena, B. C., da Silva, V. A., dos Santos, G. B., da Silva, M. C. C., Cristante, A. F., Willerth, S. M., Perrin, F. E., & Kihara, A. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01861-w · Cited by 28
The distribution of fitness effects of plasmid pOXA-48 in clinical enterobacteria
Fernández-Calvet, A., Toribio-Celestino, L., Valle, A. A.-D., Sastre-Domínguez, J., Valdés-Chiara, P., Millán, Á. S., & DelaFuente, J. (2023) · Microbiology · doi:10.1099/mic.0.001369 · Cited by 28
Alam, S., Anugraham, M., Huang, Y., Kohler, R. S., Hettich, T., Winkelbach, K., Grether, Y., López, M. N., Khasbiullina, N. R., Bovin, N. V., et al. (2017) · Scientific Reports · doi:10.1038/srep45367 · Cited by 28
Genetics of Cardiovascular Disease: Fishing for Causality
Paone, C., Diofano, F., Park, D.-D., Rottbauer, W., & Just, S. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00060 · Cited by 27
Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes
Wang, Y., Wang, B., Xie, H., Ren, Q., Liu, X., Li, F., Lv, X., He, X., Cheng, C., Deng, R., et al. (2019) · Biotechnology Journal · doi:10.1002/biot.201800689 · Cited by 26
Yuan, P., Usman, M. A., Liu, W., Adhikari, A., Zhang, C., Njiti, V. N., & Xia, Y. (2024) · Biotechnology Journal · doi:10.1002/biot.202400457 · Cited by 26
CRISPR/Cas9-Edited Rice: A New Frontier for Sustainable Agriculture
Mehta, S., Lal, S. K., Sahu, K. P., Venkatapuram, A. K., Kumar, M., Sheri, V., Panditi, V., Vishwakarma, C., Yadav, R., Jameel, M. R., et al. (2020) · Springer eBooks · doi:10.1007/978-981-15-1322-0_23 · Cited by 27
Jin, Y. H., Liao, B., Migaud, H., & Davie, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-69421-0 · Cited by 27
McGuire, C. M., Collins, M. P., Sun‐Wada, G., Wada, Y., & Forgac, M. D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007713 · Cited by 25
CRISPR for Neuromuscular Disorders: Gene Editing and Beyond
Young, C. S., Pyle, A. D., & Spencer, M. J. (2019) · Physiology · doi:10.1152/physiol.00012.2019 · Cited by 25
Dabrowska, M., Czubak, K., Juzwa, W., Krzyżosiak, W. J., Olejniczak, M., & Kozłowski, P. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky505 · Cited by 25
Hii, A. R. K., Qi, X., & Wu, Z. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb01850d · Cited by 26
CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases
Rasoulinejad, S. A., & Maroufi, F. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00345-4 · Cited by 24
CRISPRroots: on- and off-target assessment of RNA-seq data in CRISPR–Cas9 edited cells
Corsi, G. I., Gadekar, V. P., Gorodkin, J., & Seemann, S. E. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1131 · Cited by 25
Subburaj, S., Zanatta, C. B., Nunn, J. A. L., Hoepers, A. M., Nodari, R. O., & Agapito-Tenfen, S. Z. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.939997 · Cited by 25
Mackon, E., Mackon, G. C. J. D. E., Guo, Y., Ma, Y., Yao, Y., & Liu, P. (2023) · Plant Science · doi:10.1016/j.plantsci.2023.111746 · Cited by 23
Enhancing Horticultural Crops through Genome Editing: Applications, Benefits, and Considerations
Daniel, M. A., Raveendar, S., Yu, J., Packiam, S. M., & Chung, J. (2023) · Horticulturae · doi:10.3390/horticulturae9080884 · Cited by 24
Denbow, C. J., Lapins, S., Dietz, N., Scherer, R., Nimchuk, Z. L., & Okumoto, S. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01171 · Cited by 23
Chen, J., Aimanova, K. G., & Gill, S. S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007948 · Cited by 23
Newman, A., Starrs, L. M., & Burgio, G. (2020) · BioEssays · doi:10.1002/bies.202000047 · Cited by 26
Genome-wide specificity of plant genome editing by both CRISPR–Cas9 and TALEN
Bessoltane, N., Charlot, F., Guyon‐Debast, A., Charif, D., Mara, K., Collonnier, C., Perroud, P., Tepfer, M., & Nogué, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-13034-2 · Cited by 25
CRISPR Editing Technology in Biological and Biomedical Investigation
White, M. K., Kaminski, R., Young, W., Roehm, P. C., & Khalili, K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26099 · Cited by 25
Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
Meaker, G. A., Hair, E. J., & Gorochowski, T. E. (2020) · Synthetic Biology · doi:10.1093/synbio/ysaa021 · Cited by 22
Nguyen, T. H., Taieb, S. B., Moritaka, M., Liu, R., & Fukuda, S. (2021) · Journal of International Food & Agribusiness Marketing · doi:10.1080/08974438.2021.2011526 · Cited by 21
An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
Roueinfar, M., Templeton, H., Sheng, J. A., & Hong, K. L. (2022) · Molecules · doi:10.3390/molecules27031114 · Cited by 21
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 21
Yang, Y., Li, J., Zou, Q., Ruan, Y., & Feng, H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.018 · Cited by 21
Deletion of transcription factor binding motifs using the CRISPR/spCas9 system in the β-globin LCR
Kim, Y. W., & Kim, A. (2017) · Bioscience Reports · doi:10.1042/bsr20170976 · Cited by 19
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 21
Colijn, S., Yin, Y., & Stratman, A. N. (2022) · Developmental Biology · doi:10.1016/j.ydbio.2022.02.003 · Cited by 19
CRISPR genome engineering for retinal diseases
Kantor, A., McClements, M. E., Peddle, C. F., Fry, L. E., Salman, A., Cehajic‐Kapetanovic, J., Xue, K., & MacLaren, R. E. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.024 · Cited by 19
CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2
Shademan, B., Nourazarian, A., Hajazimian, S., Isazadeh, A., Avci, Ç. B., & Oskouee, M. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.772788 · Cited by 18
CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
Yrigollen, C. M., & Davidson, B. L. (2019) · Brain Sciences · doi:10.3390/brainsci9010017 · Cited by 19
Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing
Lomov, N. A., Viushkov, V. S., Petrenko, A. P., Syrkina, M. S., & Rubtsov, M. A. (2019) · Molecular Biology · doi:10.1134/s0026893319060116 · Cited by 20
From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors
Shoari, A. (2025) · Targets · doi:10.3390/targets3010008 · Cited by 19
In Vitro Production of (Farm) Animal Embryos
Wrenzycki, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-92327-7_12 · Cited by 14
A strategy to complement PtAUREO1a in TALEN knockout strains of Phaeodactylum tricornutum
Madhuri, S., Bártulos, C. R., Serif, M., Bernard, L., & Kroth, P. G. (2019) · Algal Research · doi:10.1016/j.algal.2019.101469 · Cited by 17
Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs
Li, P. P., & Margolis, R. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-89312-2 · Cited by 16
Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases
Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019) · Angewandte Chemie · doi:10.1002/ange.201903618 · Cited by 15
CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING
Cho, G. Y., Schaefer, K. A., Bassuk, A. G., Tsang, S. H., & Mahajan, V. B. (2018) · Retina · doi:10.1097/iae.0000000000002197 · Cited by 15
Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
Yamaguchi, T., Uchida, E., Okada, T., Ozawa, K., Onodera, M., Kume, A., Shimada, T., Takahashi, S., Tani, K., Nasu, Y., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.156 · Cited by 16
Role of induced pluripotent stem cells in lysosomal storage diseases
Kido, J., Nakamura, K., & Era, T. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103540 · Cited by 16
Genome engineering technologies in rabbits
Song, J. W., Zhang, J., Xu, J., Garcia-Barrio, M. T., Chen, Y. E., & Yang, D. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190133 · Cited by 16
Brara, Z., Madani, K., Costa, J. S., Taouzinet, L., Djaoudene, O., Amrane‐Abider, M., Bougherra, H. H., Mouhoubi, K., Brahimi, N., Bouiche, C., et al. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70243 · Cited by 14
CRISPR-edited plants’ social, ethical, policy, and governance issues
Munawar, N., Ahsan, K., & Ahmad, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18444-4.00011-9 · Cited by 14
Yang, Y., Zheng, Y., Zou, Q., Li, J., & Feng, H. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012340 · Cited by 14
Decoding Sanger Sequencing Chromatograms from CRISPR-Induced Mutations
Xie, X., Ma, X., & Liu, Y. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8991-1_3 · Cited by 14
Đào, T. T., de Mattos-Shipley, K. M. J., Prosser, I. M., Williams, K., Zacharova, M. K., Lazarus, C. M., Willis, C. L., & Bailey, A. M. (2021) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2021.632542 · Cited by 14
Gene Editing in Channel Catfish via Double Electroporation of Zinc-Finger Nucleases
Dunham, R. A., Elaswad, A., & Qin, Z. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8799-3_15 · Cited by 14
Xu, H., Liu, R., Zhou, H., Kong, B., Shen, K., Zhao, T., Du, X., Zhang, H., Song, H., Guo, D., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.029 · Cited by 15
Jamehdor, S., Pajouhanfar, S., Saba, S., Uzan, G., Teimoori, A., & Naserian, S. (2022) · Cells · doi:10.3390/cells11060999 · Cited by 13
Sagarbarria, M. G. S., Caraan, J. A. M., & Layos, A. J. G. (2023) · Transgenic Research · doi:10.1007/s11248-023-00371-9 · Cited by 13
CRISPR/Cas9: an overview of recent developments and applications in cancer research
Devi, S. N., Rana, R., Malik, P., & Ganguly, N. K. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001081 · Cited by 14
Lemmens, M., Dorsheimer, L., Zeller, A., & Dietz, Y. (2024) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2024.503767 · Cited by 15
Khumsupan, P., Donovan, S., & McCormick, A. J. (2019) · Physiologia Plantarum · doi:10.1111/ppl.12937 · Cited by 14
Xie, Y., Zhong, Y., Chang, J., & Kwan, H. S. (2020) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2020.103485 · Cited by 13
Nguyen, T. H., Taieb, S. B., Moritaka, M., & Fukuda, S. (2022) · Journal of Food Products Marketing · doi:10.1080/10454446.2022.2037487 · Cited by 13
Gonzalez-Salinas, F., Martínez-Amador, C., & Treviño, V. (2022) · Gene · doi:10.1016/j.gene.2022.146595 · Cited by 12
Anticipating emerging biotechnology threats
Vogel, K. M., & Ouagrham-Gormley, S. B. (2018) · Politics and the Life Sciences · doi:10.1017/pls.2018.21 · Cited by 14
Kulcsár, P. I., Tálas, A., Ligeti, Z., Tóth, E., Rakvács, Z., Bartos, Z., Krausz, S. L., Welker, Á., Végi, V. L., Huszár, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41393-5 · Cited by 14
CRISPR/Cas9 gene editing in peanut by Agrobacterium tumefaciens-mediated pollen tube transformation
Li, A., Zhou, M., Liao, G., Li, X., Wang, A., Xiao, D., He, L., & Zhan, J. (2023) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-023-02607-2 · Cited by 12
Application of CRISPR Technology in Plant Improvement: An Update Review
Saini, H., Devrani, A., Synrem, G. J., & Priyanka (2025) · Advances in Agriculture · doi:10.1155/aia/4578877 · Cited by 15
Singh, D. D., Hawkins, R. D., Lahesmaa, R., & Tripathi, S. K. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.007 · Cited by 13
Milon, N., Chantry-Darmon, C., Satgé, C., Fustier, M., Cauet, S., Moreau, S., Callot, C., Bellec, A., Gabrieli, T., Saïas, L., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz632 · Cited by 12
Michalski, K., Hertig, C. W., Mańkowski, D. R., Kumlehn, J., Zimny, J., & Linkiewicz, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137038 · Cited by 12
Žužić, M., Striebel, J., Pawlick, J. S., Sharma, K., Holz, F. G., & Busskamp, V. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101065 · Cited by 12
Методы оценки эффективности работы систем CRISPR/Cas при геномном редактировании
Lomov, N. A., Viushkov, V. S., Petrenko, A. P., Syrkina, M. S., & Rubtsov, M. A. (2019) · Molecular Biology · doi:10.1134/s0026898419060119 · Cited by 12
Challenges and opportunities for strain verification by whole-genome sequencing
Gallegos, J. E., Häyrynen, S., Adames, N. R., & Peccoud, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-62364-6 · Cited by 12
Biswas, S., Li, R., Hong, J., Zhao, X., Yuan, Z., Zhang, D., & Shi, J. (2020) · Theoretical and Applied Genetics · doi:10.1007/s00122-020-03600-5 · Cited by 12
Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
de Almeida, N. A. A., Ribeiro, C. R. D. A., Raposo, J. V., & de Paula, V. S. (2021) · Viruses · doi:10.3390/v13050822 · Cited by 11
Molecular and Computational Strategies to Increase the Efficiency of CRISPR-Based Techniques
Mattiello, L., Rütgers, M., Sua-Rojas, M. F., Tavares, R., Soares, J. S., Begcy, K., & Menossi, M. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.868027 · Cited by 12
Nguyen, T. H., Taieb, S. B., Moritaka, M., & Fukuda, S. (2024) · Agribusiness · doi:10.1002/agr.21929 · Cited by 11
Wang, M., Schedel, M., & Gelfand, E. W. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.03.016 · Cited by 11
Schröpfer, S., & Flachowsky, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212611 · Cited by 11
Kaeuferle, T., Stief, T. A., Canzar, S., Kutlu, N. N., Willier, S. M., Stenger, D., Ferrada‐Ernst, P., Habjan, N., Peters, A. E., Busch, D. H., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1372 · Cited by 12
Tekel, S. J., Brookhouser, N., Standage-Beier, K., Wang, X., & Brafman, D. A. (2021) · Nature Protocols · doi:10.1038/s41596-021-00552-y · Cited by 12
Prime editing: A potential treatment option for β‐thalassemia
Arif, T., Farooq, A., Ahmad, F. J., Akhtar, M., & Choudhery, M. S. (2022) · Cell Biology International · doi:10.1002/cbin.11972 · Cited by 13
Swift Large-scale Examination of Directed Genome Editing
Hammouda, O. T., Böttger, F., Wittbrodt, J., & Thumberger, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213317 · Cited by 11
In Vivo Gene Editing in Lipid and Atherosclerosis Research
Giorgi, M. D., Jarrett, K. E., Vallim, T. Q. D. A., & Lagor, W. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_42 · Cited by 10
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
Teh, S. S. K., Bowland, K., Halper‐Stromberg, E., Kotwal, A., Bennett, A., Skaist, A. M., Tang, J., Cai, F., Macoretta, A., Liang, H., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae028 · Cited by 14
Delivery Methods, Resources and Design Tools in CRISPR/Cas
Aslam, M. A., Hammad, M., Ahmad, A., Altenbuchner, J., & Ali, H. (2021) · Springer eBooks · doi:10.1007/978-981-15-7142-8_3 · Cited by 10
Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit
Mollashahi, B., Latifi‐Navid, H., Owliaee, I., Shamdani, S., Uzan, G., Jamehdor, S., & Naserian, S. (2023) · Molecules · doi:10.3390/molecules28041982 · Cited by 11
A method for generating genome edited plant lines from CRISPR-transformed Shanxin poplar plants
Yang, X., Wang, J., Sun, X., Wang, P., Dou, H., Yang, Z., & Wang, Y. (2023) · Plant Science · doi:10.1016/j.plantsci.2023.111732 · Cited by 10
Generating Mutant Renal Cell Lines Using CRISPR Technologies
Perretta‐Tejedor, N., Freke, G., Seda, M., Long, D. A., & Jenkins, D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9841-8_20 · Cited by 9
Gene Editing in Potato Using CRISPR-Cas9 Technology
Chauvin, L., Sevestre, F., Lukan, T., Nogué, F., Gallois, J., Chauvin, J.-É., & Veillet, F. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1609-3_16 · Cited by 10
Novel and innovative approaches for treatment of β-thalassemia
Soni, S. (2017) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2017.11.153 · Cited by 10
CRISPR-Cas-Mediated Gene Knockout in Tomato
Swinnen, G., Jacobs, T. B., Pauwels, L., & Goossens, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9952-1_25 · Cited by 10
Brant, E. J., May, D., Eid, A., & Altpeter, F. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1505844 · Cited by 9
Yang, Z., Guo, B., Hu, C., Tang, C., Shen, Y., Zhang, B., & Wang, F. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137607 · Cited by 9
Sakthivel, S. K., Vennapusa, A. R., & Melmaiee, K. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1599242 · Cited by 10
Ghosh, S. K., & Chatterjee, T. (2024) · Springer eBooks · doi:10.1007/978-981-99-8529-6_22 · Cited by 10
New Breeding Techniques: Detection and Identification of the Techniques and Derived Products
Bertheau, Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.21834-9 · Cited by 10
CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination
Tabassum, T., Pietrogrande, G., Healy, M. D., & Wolvetang, E. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914701 · Cited by 9
Challenges and Future Prospects of CRISPR Technology
Khan, Z., Khan, S. H., & Ahmad, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-6305-5_10 · Cited by 9
Animal Transgenesis and Cloning: Combined Development and Future Perspectives
Yamashita, M., & Melo, E. O. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3064-8_6 · Cited by 8
Ramasamy, S. P., Rathnasamy, S. A., Sudha, M., Gopalakrishnan, C., Balakrishnan, N., Swaminathan, M., Seshadri, G., & Muthurajan, R. (2025) · Physiological and Molecular Plant Pathology · doi:10.1016/j.pmpp.2025.102640 · Cited by 7
Pham, Q. T., Raad, S., Mangahas, C. L., M’Callum, M.-A., Raggi, C. C., & Paganelli, M. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.06.008 · Cited by 8
Multimodal detection of protein isoforms and nucleic acids from low starting cell numbers
Rosàs, E., Modzelewski, A. J., Martinez, A. E. G., Geldert, A., Gopal, A., He, L., & Herr, A. E. (2021) · Lab on a Chip · doi:10.1039/d1lc00073j · Cited by 7
Chemical and Biological Approaches to Interrogate off-Target Effects of Genome Editing Tools
Lei, Z., Meng, H., Zhuang, Y., Zhu, Q., & Yi, C. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00836 · Cited by 9
Detection of genome-edited cells by oligoribonucleotide interference-PCR
Fujita, T., Yuno, M., Kitaura, F., & Fujii, H. (2018) · DNA Research · doi:10.1093/dnares/dsy012 · Cited by 8
Metadata
- Authors
- Zischewski, J., Fischer, R., & Bortesi, L.
- Affiliations
- RWTH Aachen University (DE)
- Fraunhofer Institute for Molecular Biology and Applied Ecology (DE)
- Corresponding author
- Bortesi, Luisa
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 35
- Issue
- 1
- Pages
- 95-104
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2565555627
- Cited by
- 323
- References
- 78
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 32 · 2023: 31 · 2022: 35 · 2021: 41 · 2020: 40 · 2019: 46 · 2018: 37 · 2017: 18
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biotechnology Advances (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Funders
- European Research Council (269110)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- CRISPR/Cas9, off-target mutations, TALEN, zinc finger nucleases, sequence-specific nucleases, genome editing, sensitivity
- MeSH terms
- Gene Editing, Animals, Base Sequence, Cell Line, Deoxyribonucleases, Humans, Mutation, Mice, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review